Trachelogenin
Trachelogenin ((-) -Trachelogenin) is an HCV entry inhibitor without genotype specificity, and with low cytotoxicity. Trachelogenin inhibits HCVcc infection and HCVpp cell entry in a dose-dependent manner with an IC50 of 0.325 and 0.259 μg/mL in HCVcc and HCVpp models, respectively. Trachelogenin exhibits effective antiviral, anti-inflammatory and analgesic effects[1].
Product Specifications
CAS Number
[34209-69-3]
Product Name Alternative
(-) -Trachelogenin
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
HCV
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/trachelogenin.html
Purity
99.56
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O[C@]1([C@H](COC1=O)CC(C=C2)=CC(OC)=C2OC)CC(C=C3)=CC(OC)=C3O
Molecular Formula
C21H24O7
Molecular Weight
388.41
Precautions
H315, H319, H335
References & Citations
[1]Xi-Jing Qian, et al. Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81. J Gen Virol. 2016 May;97 (5) :1134-1144.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
